Correlation between Ivacaftor-induced CFTR Activation in Airway Epithelial Cells and Improved Lung Function: A Proof-of-Concept Study
- 1 August 2020
- journal article
- letter
- Published by American Thoracic Society in Annals of the American Thoracic Society
- Vol. 17 (8), 1024-1027
- https://doi.org/10.1513/annalsats.202001-082rl
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del AlleleThe New England Journal of Medicine, 2019
- Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trialThe Lancet, 2019
- Treating the Underlying Cystic Fibrosis Transmembrane Conductance Regulator Defect in Patients with Cystic FibrosisSeminars in Respiratory and Critical Care Medicine, 2019
- Stability of gene expression by primary bronchial epithelial cells over increasing passage numberBMC Pulmonary Medicine, 2018
- Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulatorsScientific Reports, 2017
- Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung InfectionsAmerican Journal of Respiratory and Critical Care Medicine, 2017
- Correlation of sweat chloride and percent predicted FEV1 in cystic fibrosis patients treated with ivacaftorJournal of Cystic Fibrosis, 2016
- A functional CFTR assay using primary cystic fibrosis intestinal organoidsNature Medicine, 2013
- Airway epithelial cells from asthmatic children differentially express proremodeling factorsJournal of Allergy and Clinical Immunology, 2012
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationThe New England Journal of Medicine, 2011